Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
doi:10.1073/pnas.0900206106
Most patients tolerate provider-guided peptide therapy well when used under medical supervision
If a medicine is not approved in your jurisdiction, routine access may not be appropriate outside a legitimate clinical trial
Dose Titration Table | Week | Tirzepatide Dose | |------|-----------------| | 1 to 4 | 2.5 mg weekly | | 5 to 8 | 5.0 mg weekly | | 9 to 12 | 7.5 mg weekly | | 13 to 16 | 10.0 mg weekly | | 17 to 20 | 12.5 mg weekly | | 21+ | 15.0 mg weekly (max) | Patients who cannot tolerate a dose increase may stay at the current dose for an additional 4 weeks before attempting the next step
US$ 25.56
US$ 23.44
US$ 26.03
US$ 24.40
US$ 20.47
US$ 20.10
